Logo
C

Centinel Spine

136 employees

Centinel Spine®, LLC is the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®). The Company’s prodisc technology is the most studied and clinically-proven TDR system across the globe, validated by over 540 published papers and 250,000 implantations worldwide. Centinel Spine continues to advance its pioneering culture and corporate mission to become a catalyst of change in the spine industry and alter the way spine surgery is perceived. The prodisc platform remains the only technology with multiple motion-preserving solutions for both cervical and lumbar anterior column reconstruction. For more information, please visit the company’s website at www.CentinelSpine.com.

Investor insights

Funding rounds participated in

$60M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Medical Equipment Manufacturing

Sectors

Medical Equipment Manufacturing

Date founded

2008

Funding rounds raised

Total raised

$60M

from 1 investors over 1 rounds

C

Centinel Spine raised $60M on March 26, 2025

Investors: SLR Capital Partners

FAQ